WNT5A and Its Receptors in the Bone-Cancer Dialogue

Stefanie Thiele1, Tilman D Rachner1, Martina Rauner1

  • 1Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität (TU) Dresden Medical Center, Dresden, Germany.

Insights

WNT5A, a Wnt signaling ligand, has varied roles in bone metastasis. It suppresses breast cancer but promotes melanoma, with an unclear role in prostate cancer, impacting bone lesion development.

Area of Science:

  • Oncology
  • Bone Biology
  • Molecular Signaling

Background:

  • Wnt signaling is crucial for cancer and bone remodeling.
  • Its role in bone metastasis formation is not well understood.
  • Wnt signaling complexity poses challenges in cancer research.

Purpose of the Study:

  • To review the role of the noncanonical Wnt ligand WNT5A in osteotropic cancers.
  • To examine WNT5A's function in bone metastasis development.
  • To discuss therapeutic strategies targeting Wnt signaling in bone metastases.

Main Methods:

  • Literature review and synthesis of existing research.
  • Focus on WNT5A's function in breast, melanoma, and prostate cancers.
  • Analysis of Wnt signaling pathways in the context of bone metastasis.

Main Results:

  • WNT5A exhibits tumor-suppressive effects in breast cancer.
  • WNT5A promotes tumor development in melanoma.
  • WNT5A's role in prostate cancer bone metastasis is ambiguous.

Conclusions:

  • WNT5A has context-dependent roles in bone metastasis.
  • Targeting Wnt signaling presents therapeutic challenges and opportunities.
  • Further research is needed to clarify WNT5A's precise role in various cancers and bone metastasis.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

2.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

1.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K